#ai-stocks

#ai-stocks

It took Warren Buffett nearly 60 years to build Berkshire Hathaway into a $1 trillion conglomerate. Eight AI companies have together gained quadruple that in market value in just over nine months. Whether you think AI stocks will keep booming or burst like the dot-com bubble, the growth of these companies has been unprecedented. Their year-to-date gains alone dwarf the total value of some of America's biggest and best-known companies.

Undoubtedly, widespread skepticism may keep the bull in check, as investors become just a bit more cautious with the basket of AI winners that have led the market so far this year. While the skeptics, bears, and doomers may be right to tilt more conservatively (think defensive dividend stocks) as we progress through September, I think most investors should not attempt to time the market.

Despite the hype surrounding artificial intelligence, C3.ai seems stuck in neutral, failing to capitalize on the sector's explosive growth. The old Wall Street adage, "buy the rumor, sell the news," doesn't quite fit here. With C3.ai, the strategy appears to be sell the rumor, sell the news, and, frankly, just sell the stock. The company's inability to turn AI enthusiasm into sales or profits, coupled with leadership turmoil, paints a grim picture for its future.

Artificial intelligence stocks have been all the rage in the stock market, with some of them producing generational returns in just a few years. Not everyone has enough time to research compelling AI stocks, but if you follow the money, you might discover a hidden goldmine. Executives have been loading up on popular AI stocks, but they have also been buying under-the-radar stocks. These are some of the top AI stocks that are attracting institutional investors.

Nebius Group expects an ARR of up to $1.1 billion for 2024, showcasing remarkable growth from $117.5 million previously, indicating its significant potential in the AI sector.

Insider selling at Nvidia reflects a normal routine, primarily for personal financial needs, with little impact on the company’s strong AI position.

After leading market gains last year, artificial intelligence (AI) stocks are at it again. Investors became more optimistic that President Trump's import tariffs won't represent as much of a headwind for companies as initially expected.

HP Inc is shifting its focus towards AI-infused products that can drive growth, despite its traditionally mature business model. Launching products like the EliteBook Ultra and OmniBook X, HP aims to tap into new tech opportunities.

Mark Cuban is determined to challenge the influence of pharmacy benefit managers in U.S. healthcare through his startup, Cost Plus Drugs, aiming for market disruption.

Agentic AI models, trained to use tools and access data, could redefine software, enhancing personalization through real-world actions and automation.